ArticleFrontiers in immunology2025

Novel nanobody-161 binds tumor necrosis factor receptor 2 (TNFR2) to exert an anti-tumor effect but does not block TNFα-binding.

Liang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.